Pacer Advisors Inc. lowered its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 56.4% during the first quarter, HoldingsChannel reports. The firm owned 13,179 shares of the health services provider’s stock after selling 17,053 shares during the quarter. Pacer Advisors Inc.’s holdings in Cigna Group were worth $3,515,000 as of its most recent SEC filing.
Several other institutional investors have also modified their holdings of CI. FAS Wealth Partners Inc. acquired a new position in shares of Cigna Group in the 1st quarter valued at approximately $231,000. Pine Valley Investments Ltd Liability Co lifted its stake in Cigna Group by 16.9% in the first quarter. Pine Valley Investments Ltd Liability Co now owns 15,858 shares of the health services provider’s stock valued at $4,230,000 after buying an additional 2,287 shares in the last quarter. DV Trading LLC boosted its holdings in shares of Cigna Group by 187.5% in the first quarter. DV Trading LLC now owns 920 shares of the health services provider’s stock valued at $245,000 after buying an additional 600 shares during the period. Parallel Advisors LLC boosted its holdings in shares of Cigna Group by 26.1% in the first quarter. Parallel Advisors LLC now owns 3,568 shares of the health services provider’s stock valued at $952,000 after buying an additional 738 shares during the period. Finally, NewEdge Advisors LLC increased its position in shares of Cigna Group by 47.8% during the first quarter. NewEdge Advisors LLC now owns 34,277 shares of the health services provider’s stock worth $9,143,000 after acquiring an additional 11,085 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.
Cigna Group Stock Performance
Shares of CI stock opened at $275.26 on Friday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The company’s fifty day simple moving average is $285.90 and its 200-day simple moving average is $281.20. The firm has a market cap of $72.73 billion, a PE ratio of 11.39, a P/E/G ratio of 0.93 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68.
Cigna Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio is 25.82%.
Analysts Set New Price Targets
A number of brokerages recently commented on CI. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their target price for the stock from $303.00 to $302.00 in a research note on Wednesday, May 20th. Jefferies Financial Group downgraded Cigna Group from a “buy” rating to a “hold” rating and dropped their price target for the company from $336.00 to $307.00 in a research note on Tuesday. Robert W. Baird set a $362.00 price target on Cigna Group in a report on Friday, July 31st. Finally, Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a research report on Tuesday, June 16th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.
Read Our Latest Stock Report on CI
Insider Buying and Selling at Cigna Group
In other news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 222,213 shares of company stock worth $64,751,950 over the last ninety days. 0.60% of the stock is currently owned by corporate insiders.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
